Cargando…

Advances in skin science enable the development of a COVID-19 vaccine

Detalles Bibliográficos
Autor principal:	Falo, Louis D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the American Academy of Dermatology, Inc. 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260504/ https://www.ncbi.nlm.nih.gov/pubmed/32485211 http://dx.doi.org/10.1016/j.jaad.2020.05.126

Ejemplares similares

Microarray patches enable the development of skin-targeted vaccines against COVID-19
por: Korkmaz, Emrullah, et al.
Publicado: (2021)

COVID-19 vaccination: science, politics and public health
por: Wright, J. Tim
Publicado: (2021)

600 Microarray patch-based adenovirus vaccines enable effective skin immunization
por: Balmert, S.C., et al.
Publicado: (2022)

Are COVID-19 Vaccine Boosters Needed? The Science behind Boosters
por: Burckhardt, Rachel M., et al.
Publicado: (2022)

Walking the Tightrope: Reevaluating science communication in the era of COVID-19 vaccines
por: Dudley, Matthew Z., et al.
Publicado: (2021)

Advancing child health and educational equity during the COVID-19 pandemic through science and advocacy
por: Gur-Arie, Rachel, et al.
Publicado: (2022)

Advancing the science of organ donor management
por: Dhanani, Sonny, et al.
Publicado: (2014)

Advancing regulatory science, advancing regulatory practice
por: Kurz, Xavier
Publicado: (2017)

Developing standard safety outcomes for COVID-19 vaccines
por: Buttery, Jim P.
Publicado: (2021)

Recent advancements in combination subunit vaccine development
por: Tan, Ming, et al.
Publicado: (2016)

Advances in Science Are Not Linear; They Are Zigzag
por: Alpert, Joseph S.
Publicado: (2022)

Factors, enablers and challenges for COVID-19 vaccine development
por: Excler, Jean-Louis, et al.
Publicado: (2023)

India’s cost-effective COVID-19 vaccine development initiatives
por: Chakraborty, Chiranjib, et al.
Publicado: (2020)

The race to a COVID-19 vaccine: opportunities and challenges in development and distribution
por: Burgos, Rodrigo M, et al.
Publicado: (2021)

Buffering reproductive science in the era of COVID-19
por: Albertini, David F.
Publicado: (2020)

032 A multicomponent skin-targeted COVID-19 vaccine elicits robust humoral and cellular immune responses
por: Balmert, S.C., et al.
Publicado: (2021)

Skin manifestations of COVID-19: A global perspective
por: Kantor, Jonathan
Publicado: (2022)

Development of vaccines for influenza disease: Opportunity costs of the COVID-19 pandemic
por: Wiemken, Timothy L., et al.
Publicado: (2021)

Four actions Australia should take to advance equitable global access to COVID‐19 vaccines
por: Gleeson, Deborah, et al.
Publicado: (2022)

Incorporating Geographic Information Science and Technology in Response to the COVID-19 Pandemic
por: Smith, Charlotte D., et al.
Publicado: (2020)

Pandemicity, COVID-19 and the limits of public health ‘science’
por: Richardson, Eugene T
Publicado: (2020)

COVID-19 Vaccine
por: Fernandes, Amanda, et al.
Publicado: (2021)

Bringing the science back into forensic science in death investigations in the Philippines during the COVID-19 pandemic
por: Jose, Jose M., et al.
Publicado: (2021)

Advancing UK regulatory science and innovation in healthcare
por: Calvert, Melanie J, et al.
Publicado: (2020)

Advancing the science of ventilator-associated pneumonia surveillance
por: Klompas, Michael
Publicado: (2012)

Effective Communication at Different Phases of COVID-19 Prevention: Roles, Enablers and Barriers
por: Mohd Hanafiah, Khayriyyah, et al.
Publicado: (2021)

Considerations on the clinical development of COVID-19 vaccine from trial design perspectives
por: Jiang, Zhiwei, et al.
Publicado: (2020)

The development of COVID-19 vaccines in the United States: Why and how so fast?
por: Kuter, Barbara J., et al.
Publicado: (2021)

Shaping the Future of Science: COVID‐19 Highlighting the Importance of GeoHealth
por: Gorris, Morgan E., et al.
Publicado: (2021)

Ensuring access and affordability through COVID-19 vaccine research and development investments: A proposal for the options market for vaccines
por: Forman, Rebecca, et al.
Publicado: (2020)

Fake Science: XMRV, COVID-19, and the Toxic Legacy of Dr. Judy Mikovits
por: Neil, Stuart J.D., et al.
Publicado: (2020)

Using Persuasion science to improve COVID-19 contact tracing
por: Sciamanna, Christopher N., et al.
Publicado: (2021)

COVID-19 vaccination in Israel
por: Muhsen, Khitam, et al.
Publicado: (2021)

The Time for COVID-19 Vaccination
por: Domingo, Esteban, et al.
Publicado: (2021)

The Vaccine Uptake Continuum: Applying Social Science Theory to Shift Vaccine Hesitancy
por: Piltch-Loeb, Rachael, et al.
Publicado: (2020)

COVID-19 vaccination in the UK: Addressing vaccine hesitancy
por: Sonawane, Kalyani, et al.
Publicado: (2021)

COVID-19 vaccines and vaccination: how prepared is Africa?
por: Ariyo, Olumuyiwa Elijah, et al.
Publicado: (2021)

Skin immunization for effective treatment of multifocal melanoma refractory to PD1 blockade and Braf inhibitors
por: Hao, Xingxing, et al.
Publicado: (2021)

Emergence of Coronavirus (COVID-19) Outbreak: Anthropological and Social Science Perspectives
por: Sonekar, Harshal B, et al.
Publicado: (2020)

Reflections During the COVID-19 Pandemic: Science, Education, and Everyday Life
por: Roth, Wolff-Michael
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rg8fjssj53542mcam914tivrcs